Prof. Mohamed El-Brawany

Professor of Biomedical Engineering
Menoufia University, Faculty of Electronic Engineering
Department of Industrial Electronics and Control Engineering
Menouf, PO Box 32952 Menouf City, Menoufia Governorate, Egypt

Email:   melbrawany@el-eng.menofia.edu.eg

melbrawany@gmail.com

Ph.D: Biomedical Engineering, St. George’s Hospital Medical School, University of London, UK, 2000.

MSc: Electronic Engineering, Faculty of Electronic Engineering, Menoufia University, Egypt, 1993.

BSc:  Electronic Engineering, Faculty of Electronic   Engineering, Menoufia University, Egypt, 1989.

2022-Now:      Vice Dean of Graduate Studies and Research, Faculty of Electronic Engineering, Menoufia University, Egypt.

2019:2022:      Professor of Biomedical Engineering, Dept of Industrial Electronics and Control Engineering, Faculty of Electronic Engineering, Menoufia University, Egypt.

2015-2018:      Head of Dept of Industrial Electronics and Control Engineering, Faculty of Electronic Engineering, Menoufia University, Egypt.

2008-2015:     Head of Dept of Biomedical Engineering, College of Engineering, University of Dammam, Kingdom of Saudi Arabia.

2004-2005:     Academic Visitor, St. George’s Hospital Medical School, University of London, London, UK.

2002-2008:     Assistant Professor, Faculty of Electronic Engineering, Menoufia University, Egypt.

2000-2002:     Post Doc position as a Clinical Scientist, St. George’s Hospital Medical School, University of London, London, UK.

2001-2002:     An honorary appointment as a Visiting Researcher at Joint Section of Physics, Institute of Cancer Research, Royal Marsden NHS Trust, Sutton, London, UK.

1996-2000:     PhD student, St. George’s Hospital Medical School, University of London, London, UK.

1993-1996:     Lecturer, Faculty of Electronic Engineering, Menoufia University, Egypt.

1990-1993:     Demonstrator, Faculty of Electronic Engineering, Menoufia University, Egypt.

• Medical Ultrasound,
• MRI-Guided Ultrasound Cancer Therapy
• Safety of Diagnostic Ultrasound
• Modeling and Control of Physiological systems,
• Biomedical Signal Processing,
• Rehabilitation Engineering

• Mohamed E Karar, Sahar H El-Khafif and Mohamed A El-Brawany, "Automated Diagnosis of Heart Sounds Using Rule-Based Classification Tree", J Med Syst (2017) 41:60. DOI: 10.1007/s10916-017-0704-9.
• Ahmed H. El-Garawany, Mohamed E. Karar and Mohamed A. El-Brawany, “Embedded Drug Delivery Controller for Cancer Chemotherapy Under Treatment Constraints” IEEE 5^th  International Conference on Advanced Control, Circuits and Systems (ACCS’017), & 2017 Intl Conf on New Paradigms in Electronics & Information Technology (PEIT), 5-8 November, 2017. DOI: 10.1109/ACCS-PEIT.2017.8303050
• Mohamed E Karar and Mohamed A El-Brawany, “Fully-Tuned RBF Neural Network Controller for Ultrasound Hyperthermia Cancer Tumour Therapy”, Network: Computation in Neural Systems, Vol 29, Issue 1-4, pp 20-36, 2018. DOI: 10.1080/0954898X.2018.1539260
• Mohamed E Karar, Ahmed H. El-Garawany and Mohamed A El-Brawany “Optimal Adaptive Intuitionistic Fuzzy Logic Control of Anti-Cancer Drug Delivery Systems” Accepted for publication in Journal of Biomedical Signal Processing and Control, Oct 2019.
• T. Khalifa, A. El-Nagar, M. El-Brawany, E. El-Araby, and M. El-Bardini, “A novel fuzzy Wiener-based nonlinear modelling for engineering applications,” ISA Transactions, vol. 97, pp. 130–142, 2020. https://doi.org/10.1016/j.isatra.2019.07.017
• T. Khalifa, A. El-Nagar, M. El-Brawany, E. El-Araby, and M. El-Bardini,“A Novel Hammerstein Model for Nonlinear Networked Systems Based on an Interval Type-2 Fuzzy Takagi-Sugeno-Kang System,”  IEEE Transactions on Fuzzy Systems, vol. 29, pp. 275-285, 2021.
• A. El-Nagar, T. Khalifa, M. El-Brawany, M. El-Bardini, and E. El-Araby,“Adaptive Interval Type-2 Fuzzy Controller for Nonlinear Networked Wiener Systems Subject to Packet Dropout and Time-Varying Delay,” ISA Transactions, 2021. ISSN 0019-0578, https://doi.org/10.1016/j.isatra.2021.10.018.
• El-Brawany M. A., “A compartmental diabetic model with intravenous and subcutaneous insulin infusion” in preparation.